Orient EuroPharma Co., Ltd. (TPEX: 4120)

Orient EuroPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,397	1,736	1,801	1,959	2,121	1,752
Short-Term Investments	178.21	365.97	70.8	80.8	201.8	81.8
Cash & Short-Term Investments	1,575	2,102	1,872	2,040	2,323	1,834
Cash Growth	-20.23%	12.30%	-8.25%	-12.19%	26.68%	-4.61%
Accounts Receivable	789.69	783.01	730.48	580.03	524.06	703.03
Other Receivables	29.19	26.94	27.66	33.53	18.17	20.93
Receivables	818.88	809.94	758.15	613.55	542.23	723.96
Inventory	1,179	1,147	1,304	1,082	1,350	1,478
Prepaid Expenses	126.94	118.23	162.21	136.07	87.96	142.99
Other Current Assets	264.99	50.83	88.62	53.63	13.89	6.24
Total Current Assets	3,965	4,228	4,185	3,925	4,317	4,185
Property, Plant & Equipment	3,902	3,986	4,019	4,181	2,894	2,827
Long-Term Investments	3,135	1,064	533.57	416.83	191.06	145.7
Other Intangible Assets	43.54	42.69	43.01	78.16	104.48	123.98
Long-Term Deferred Tax Assets	648.52	677.16	588.05	631.87	522.46	507.06
Other Long-Term Assets	814.76	814.28	1,062	170.82	130.57	83.5
Total Assets	12,509	10,812	10,430	9,403	8,160	7,873
Accounts Payable	213.37	348.07	552.2	159.81	318.76	334.4
Accrued Expenses	245.14	280.31	353.04	390.66	456.17	429.59
Short-Term Debt	2,644	2,324	2,191	2,050	1,225	1,195
Current Portion of Long-Term Debt	439.31	272.31	350.18	246.82	158.57	91.53
Current Portion of Leases	41.98	41.95	44.06	25.78	32.41	31.34
Current Income Taxes Payable	24.83	138.39	16.02	55.52	13.76	56.1
Current Unearned Revenue	-	-	-	-	-	99.28
Other Current Liabilities	352.39	307.18	286.42	303.12	224.54	178.5
Total Current Liabilities	3,961	3,712	3,793	3,232	2,429	2,416
Long-Term Debt	1,481	1,790	1,991	1,680	758.28	617.48
Long-Term Leases	384.17	412.89	447.92	218.46	229.47	233.59
Long-Term Deferred Tax Liabilities	665.56	651.99	671.26	728.29	746.01	692.84
Other Long-Term Liabilities	22.64	23.44	23.3	24.65	26.83	27.2
Total Liabilities	6,562	6,649	6,987	5,950	4,255	4,061
Common Stock	867.47	867.47	867.47	867.47	867.47	867.47
Additional Paid-In Capital	271.26	271.26	271.26	263.44	260.77	246.84
Retained Earnings	1,434	1,752	1,738	2,118	2,274	2,174
Comprensive Income & Other	2,724	624.12	51.9	-307.04	-193.43	-93.67
Total Common Equity	5,296	3,514	2,929	2,942	3,209	3,195
Minority Interest	651.11	648	514.77	511.39	696.34	617.18
Shareholders' Equity	5,947	4,162	3,444	3,453	3,905	3,812
Total Liabilities & Equity	12,509	10,812	10,430	9,403	8,160	7,873
Total Debt	4,991	4,841	5,024	4,221	2,403	2,169
Net Cash (Debt)	-3,415	-2,739	-3,153	-2,181	-80.19	-335.07
Net Cash Per Share	-39.28	-31.50	-36.34	-25.08	-0.92	-3.85
Filing Date Shares Outstanding	86.75	86.75	86.75	86.75	86.75	86.75
Total Common Shares Outstanding	86.75	86.75	86.75	86.75	86.75	86.75
Working Capital	4.77	515.42	391.79	693.29	1,888	1,769
Book Value Per Share	61.05	40.51	33.76	33.91	36.99	36.83
Tangible Book Value	5,253	3,472	2,886	2,864	3,104	3,071
Tangible Book Value Per Share	60.55	40.02	33.27	33.01	35.78	35.40
Land	1,168	1,169	1,169	1,462	578.12	438.37
Buildings	2,350	2,347	2,243	2,190	1,754	1,739
Machinery	1,080	1,069	992.9	965.5	918.07	933.79
Construction In Progress	3.62	3.55	36.12	48.41	0.88	10.73

Source: S&P Capital IQ. Standard template. Financial Sources.